RDC-0313: Phase 2 Randomized, Double-blind, Placebo-cont

Project: Research project

Project Details

Description

RDC-0313: Phase 2 Randomized, Double-blind, Placebo-controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults with Binge Eating Disorder
StatusFinished
Effective start/end date8/1/107/31/13

Funding

  • Alkermes, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.